Molecular Diagnosis of Mumps - Mitigation of Resurgence, A South Indian Report

N Ashokumar1, K Jaya Swathi2, Senthilraja Ramalingam2

  • 1Molecular Biologist, Department of Molecular Biology, Microbiological Laboratory, Deralakatta, Mangalore, India.

PubMed
Abstract

Insights

Mumps virus infections, a public health concern, were diagnosed in 13% of suspected cases in India using advanced PCR testing. This highlights the need for accessible diagnostic methods to reduce mumps complications.

Area of Science:

  • Virology
  • Public Health
  • Infectious Diseases

Background:

  • Mumps virus infection is a significant public health issue, characterized by parotid gland swelling and potential complications like meningitis and orchitis.
  • The COVID-19 pandemic negatively impacted global mumps vaccination efforts, potentially leading to increased disease incidence.

Purpose of the Study:

  • To assess the prevalence of mumps virus infection in suspected cases in southern India.
  • To evaluate the utility of advanced diagnostic techniques for mumps detection in a resource-limited setting.

Main Methods:

  • A prospective study was conducted from January to March 2024.
  • Samples from 200 suspected mumps patients were analyzed using fast-track diagnostics reverse transcription polymerase chain reaction (RT-PCR) kits.
  • Cases were classified according to the World Health Organization (WHO) clinical case definition.

Main Results:

  • Out of 200 samples screened, 26 (13%) tested positive for mumps virus.
  • Positive results were obtained from blood (10), cerebrospinal fluid (11), and buccal swabs (5).

Conclusions:

  • Advanced diagnostic methods like RT-PCR are crucial for accurately identifying mumps virus infections.
  • Implementing robust laboratory testing in developing countries like India can significantly reduce mumps-related morbidity and mortality.